Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 18-001877
    NCT ID: NCT03375489
    Sponsor Protocol Number: PCRC 17-11

About this study

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria - Patient:

  • Diagnosed with advanced NSCLC being treated with non-curative intent, and informed of advanced disease within the prior 8-12 weeks.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day).
  • The ability to read and respond to questions in English or Spanish.
  • Lives in a state where their institutions’ PC clinicians are licensed to practice.
  • Receiving primary cancer care at one of the participating sites.
  • Age > 18 years.

Inclusion Criteria - Caregiver:

  • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week.
  • The ability to read and respond to questions in English or Spanish.
  • Age ≥ or 18 years.

Exclusion Criteria - Patient:

  • Already receiving PC or hospice services.
  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Exclusion Criteria - Caregiver:

  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Leventakos, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20425293

Mayo Clinic Footer